Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.4 updated from v3.5.3 on the page. This change reflects a backend/content version bump rather than alterations to the study details or public-facing information.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new Revision: v3.5.3 tag was added to the page, indicating an update from the previous revision (v3.5.2).SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.0%

- Check63 days agoChange DetectedSite revision indicator updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check77 days agoChange DetectedUpdated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check106 days agoChange DetectedRevision: v3.4.2 was added. The funding-status notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.